Astrazeneca (AZN) P/B (1999 - 2026)
Astrazeneca (AZN) P/B from Nov 1, 1999 to Jul 20, 2026. The TTM Astrazeneca (AZN) P/B is 5.42. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Astrazeneca (AZN)
| Year | P/B | Change |
|---|---|---|
| 2026 | 5.42 | -8.12% |
| 2025 | 5.90 | +17.59% |
| 2024 | 5.02 | -11.16% |
| 2023 | 5.65 | -6.11% |
| 2022 | 6.02 | +31.10% |
| 2021 | 4.59 | -45.38% |
| 2020 | 8.40 | -15.69% |
| 2019 | 9.97 | +29.12% |
| 2018 | 7.72 | +20.49% |
| 2017 | 6.41 | +21.07% |
| 2016 | 5.29 | +13.91% |
| 2015 | 4.65 | +2.41% |
| 2014 | 4.54 | +41.28% |
| 2013 | 3.21 | +29.19% |
| 2012 | 2.49 | -5.46% |
| 2011 | 2.63 | -12.68% |
| 2010 | 3.01 | -8.56% |
| 2009 | 3.29 | -11.77% |
| 2008 | 3.73 | -11.62% |
| 2007 | 4.22 | -24.19% |
| 2006 | 5.57 | +247.46% |
| 2005 | 1.60 | +33.55% |
| 2004 | 1.20 | -24.78% |
| 2003 | 1.60 | +37.87% |
| 2002 | 1.16 | -24.70% |
| 2001 | 1.54 | -9.51% |
| 2000 | 1.70 | +23.35% |
| 1999 | 1.38 | N/A |
Comparison Astrazeneca (AZN) P/B with competitors
Astrazeneca (AZN) P/B is 5.42.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.68 | -87.38% |
| GRFS | Grifols SA | 0.79 | -85.43% |
| SNY | Sanofi | 1.27 | -76.58% |
| BIIB | Biogen Inc | 1.52 | -71.98% |
| PFE | Pfizer Inc | 1.55 | -71.45% |
| OGN | Organon & Company | 3.93 | -27.59% |
| MIRA | Mira Pharmaceuticals Inc | 4.09 | -24.54% |
| GSK | GSK Plc | 4.37 | -19.36% |
| BMY | Bristol-Myers Squibb Company | 6.04 | +11.40% |
| MRK | Merck & Co Inc | 6.68 | +23.21% |
| GILD | Gilead Sciences Inc | 6.94 | +28.00% |
| NVO | Novo Nordisk | 7.07 | +30.40% |
| NVS | Novartis AG | 7.60 | +40.18% |
| JNJ | Johnson & Johnson | 7.64 | +40.91% |
| NSRX | Nasus Pharma Ltd | 12.90 | +137.93% |
| MDCX | MDCorp | 15.34 | +182.93% |
| AMGN | AMGEN Inc | 21.17 | +290.46% |
| SCLX | Scilex Holding Company | 28.85 | +432.11% |
| LLY | Lilly(Eli) & Company | 32.94 | +507.55% |
| ABBV | Abbvie Inc | 50.46 | +830.69% |